IAVI works closely with a wide array of partners to advance efforts to ensure the development of preventive HIV vaccines. Here you can access important news from our partners.

If you are an IAVI partner and would like to submit an item for inclusion on this page, please email your request to This email address is being protected from spambots. You need JavaScript enabled to view it..


HIV vaccine design should adapt as the virus mutates, according to new research led by scientists from Microsoft, the University of Alabama at Birmingham and Emory University (Emory, UAB)


The newly unveiled Kenya HIV/AIDS Research Agenda (2014-2019) aims to increase domestic HIV research financing (Key Correspondents)